Service Description

CRO conducted preclinical tox study using mice xenograft stydy with implanted ovarian cancer cells to determine safety and the NEL dose as well as maximal tolerated dose.

What Went Well

Proposal was produce quickly and the description of the services was very comprehensive. The study was conducted as per protocol and staff clearly knew very well their respective jobs. The report provided all the right information and required very little editing. Overall a great job.

What Could Be Improved

Study start-up could have been a bit faster. Otherwise, no complaints

Lessons Learned from the Experience

One should work with the CRO that has extensive expertise in the particular therapeutic area. Project manager who is competent and communicates well is critical.